News Category
Oncotelic Therapeutics announced that its Phase 1b trial of Sapu003 passed an initial safety review with no dose-limiting toxicities, and the company ...
GeoVax Labs announced the formation of an Oncology Advisory Board with three experts to advance Gedeptin, a gene-directed enzyme prodrug therapy, in c...
